You are here » Home » Companies » Company Overview » Nutraplus India Ltd

Nutraplus India Ltd.

BSE: 524764 Sector: Health care
NSE: N.A. ISIN Code: INE230G01020
BSE LIVE 12:45 | 22 Sep 27.10 -0.85
(-3.04%)
OPEN

27.95

HIGH

27.95

LOW

26.60

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 27.95
PREVIOUS CLOSE 27.95
VOLUME 10839
52-Week high 40.95
52-Week low 19.60
P/E
Mkt Cap.(Rs cr) 92
Buy Price 26.70
Buy Qty 639.00
Sell Price 27.10
Sell Qty 301.00
OPEN 27.95
CLOSE 27.95
VOLUME 10839
52-Week high 40.95
52-Week low 19.60
P/E
Mkt Cap.(Rs cr) 92
Buy Price 26.70
Buy Qty 639.00
Sell Price 27.10
Sell Qty 301.00

Nutraplus India Ltd. (NUTRAPLUSINDIA) - Company History

Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.'90. It was subsequently converted into a public limited company with effect from 13 Jun.'92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur, Maharashtra. Initially, the company set up manufacturing facilities for the manufacture of methyl nitro imidazole, an intermediate of DMZ, with an installed capacity of 240 tpa, at a cost of Rs 123.66 lac, for which was sanctioned a term loan of Rs 60 lac from the Maharashtra State Financial Corporation (MSFC). The company has set-up new product Roxarsone from Jan'96 and also set up production of Dinitolmide. During 2001-02 the company set up a production of newly developed Bulk Drugs Metformin HCL. It is also planning to foray in the manufacture of life saving drugs.